Get the Stockscreener App
3.30
7.84%
0.24
After Hours:
3.30
Heartsciences Inc stock is traded at $3.30, with a volume of 3,945.
It is up +7.84% in the last 24 hours and up +10.00% over the past month.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
See More
Previous Close:
$3.06
Open:
$3.36
24h Volume:
3,945
Relative Volume:
0.28
Market Cap:
$3.73M
Revenue:
-
Net Income/Loss:
$-7.29M
P/E Ratio:
-0.1354
EPS:
-24.3686
Net Cash Flow:
$-6.81M
1W Performance:
-5.71%
1M Performance:
+10.00%
6M Performance:
+3.77%
1Y Performance:
-67.33%
1-Day Range:
$3.06
$3.36
1-Week Range:
$2.9737
$3.8295
52-Week Range:
$2.36
$13.50
Heartsciences Inc Stock (HSCS) Company Profile
Name
Heartsciences Inc
Sector
Industry
Phone
682-237-7781
Address
550 RESERVE ST, SUITE 360, SOUTHLAKE
Compare HSCS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HSCS
Heartsciences Inc
|
3.30 | 3.73M | 0 | -7.29M | -6.81M | -24.37 |
|
ABT
Abbott Laboratories
|
130.98 | 221.92B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.12 | 139.43B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
346.50 | 134.90B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
82.60 | 108.02B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
71.53 | 40.93B | 5.72B | 4.17B | 259.90M | 6.97 |
Heartsciences Inc Stock (HSCS) Latest News
Lifestyle Icon Martha Stewart Confirmed As Vivid Sydney 2025's Global Storyteller - Barchart.com
This AI Company Is Solving A 100+ Year-Old Health Problem - Barchart.com
Eagle Eye Appoints Chief Revenue Officer, Jeff Baskin, to Accelerate Growth in North America - Barchart.com
/R E P E A T -- LASSONDE INDUSTRIES INC. WILL HOLD A CONFERENCE CALL TO DISCUSS ITS Q4 AND FISCAL 2024 RESULTS/ - Barchart.com
HeartSciences faces Nasdaq delisting over equity shortfall By Investing.com - Investing.com Canada
HeartSciences faces Nasdaq delisting over equity shortfall - Investing.com
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2025 Financial Results - The Manila Times
HeartSciences Reports Third Quarter Fiscal 2025 Financial Results and Business Update on AI-Powered ECG Innovations - Nasdaq
HeartSciences Q3: AI-ECG Breakthrough Nears FDA Milestone as CMS Backs Reimbursement - StockTitan
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
HeartSciences Inc. Engages Integrous Communications to Enhance Investor Communications - The Manila Times
AI Medical Tech Firm HeartSciences Strengthens Investor Communications Strategy - StockTitan
HeartSciences grants stock options to executives and directors - MSN
HeartSciences grants stock options to executives and directors By Investing.com - Investing.com South Africa
Becton, Dickinson And Company's Q1 2025 Earnings: What To Expect - Barchart.com
Scientists Discover Heart-Saving Powers in Olive, Grape, Garlic, Rosemary, and Saffron - SciTechDaily
HeartSciences Inc. withdraws IPO registration - Investing.com
HeartSciences Inc. withdraws IPO registration By Investing.com - Investing.com UK
Biogen Stock: Is BIIB Underperforming The Healthcare Sector? - Barchart.com
HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2025 Financial Results - The Manila Times
HeartSciences Advances AI-Powered ECG Platform, FDA Submission Set for Q1 2025 - StockTitan
Anteris Technologies Prices $88.8M Nasdaq IPO for Revolutionary Heart Valve Development - StockTitan
Bill Otten Joins Hello Heart as Commercial President - Medical Product Outsourcing
David Chung Lands Top Job at Heart Repair Technologies - Medical Product Outsourcing
HeartSciences' AI-ECG Algorithms Assigned CMS Medicare and Medicaid Reimbursement - The Manila Times
HeartSciences’ AI-ECG Algorithms Assigned CMS Medicare and Medicaid Reimbursement - GlobeNewswire
HeartSciences Secures $125 Medicare Reimbursement for AI-ECG Tech, Awaits FDA Nod | HSCSW Stock News - StockTitan
HeartSciences shareholders approve auditor and meeting adjournment - Investing.com India
HeartSciences shareholders approve auditor and meeting adjournment By Investing.com - Investing.com UK
Clear Secure: Q3 Earnings Snapshot - Barchart.com
Contrasting Heart Test Laboratories (NASDAQ:HSCS) and Bone Biologics (NASDAQ:BBLG) - Defense World
Investor Alert: Halo Collective, Inc. And Its Missing Continuous Disclosure Documents - Barchart.com
Heart Test Laboratories announces corporate name change to HeartSciences - Investing.com India
What To Expect From Pfizer's Q3 2024 Earnings Report - Barchart.com
HeartSciences to Participate in the 2024 Maxim Healthcare Virtual Summit - The Manila Times
Earnings Preview: What To Expect From Intuitive Surgical's Report - Barchart.com
3 Penny Stocks to Watch Now, 9/25/24 - MSN
Why Maison Solutions Shares Are Trading Higher By Around 91%; Here Are 20 Stocks Moving Premarket - Benzinga
Shares of HeartSciences get a bump from announcement of non-dilutive financing - Kursiv Media
HeartSciences Provides Business Update and Reports First Quarter Fiscal 2025 Financial Results - GlobeNewswire
HeartSciences reports fiscal 2024 financial results - Medical Buyer
Innovation Value Institute Analysis Demonstrates HeartSciences’ MyoVista® wavECG™ Potential to Improve Cardiovascular Pathway Efficiency - GlobeNewswire
HeartSciences Selected to Demonstrate MyoVista® wavECG™ at the United Nations General Assembly Digital Health Symposium as a Technology to Radically Transform Healthcare - GlobeNewswire
HeartSciences Adds Another International Patent to its IP Portfolio - MPO-mag
HeartSciences Announces Allowance of U.S Patent for AI-ECG Assessment of Left Ventricular and Right Ventricular Heart Dysfunction - Diagnostic and Interventional Cardiology
Alexandria Real Estate Equities, Inc. Releases 2023 Corporate Responsibility Report Highlighting Its Longstanding Leadership at the Vanguard and Heart of the Life Science Industry - PR Newswire
Cardiomatics Cooperates with the Biotronik Sales Organization in Germany to Accelerate the Growth of its Leading AI-powered ECG Analysis Solution in the German Market - Diagnostic and Interventional Cardiology
HeartSciences Announces Further Internationalization of its AI-ECG Patent Portfolio - GlobeNewswire
US Stocks Edge Higher; Applied Materials Posts Upbeat Earnings - Benzinga
Heart Test Laboratories (HSCS) Stock Forecast and Price Target 2024 - MarketBeat
Heartsciences Inc Stock (HSCS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.01%
0.46%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):